• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Nodality

edit

Nodality, Inc., a biotechnology company, discovers and develops personal diagnostics characterizing cell signaling pathways in defined cellular sub-populations of malignant and normal cells from individual patients. The company focuses on hematological malignancies and autoimmune disorders. Nodality, Inc. was incorporated in 2003 and is based in San Francisco, California with an additional office in Franklin, Tennessee.

Recent Milestones

edit

• 
  Nodality received $2M in Venture Round funding. (3/22/10)
  Posted 3/22/10 at 4:23pm via fiercebiotech.com
• 
  Nodality received $3.5M in Series C funding. (1/17/10)
  Posted 1/19/10 at 10:34pm via onbiovc.com
• 
  Nodality received $10M in Series C funding. (1/13/10)
  Posted 1/14/10 at 11:12pm via venturebeat.com
• 
  Nodality received $1.54M in Series A funding. (8/17/06)
  Posted 4/29/10 at 8:06pm
• 
  Nodality added David R. Parkinson as CEO.
  Posted 1/14/10 at 11:11pm
• 
  Nodality added Garry P. Nolan as Co-founder.
  Posted 1/14/10 at 11:11pm
• 
  Nodality added Omar D. Perez as Co-founder.
  Posted 5/26/10 at 7:23pm

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/15/10

Sources

1. EDGAR [edit]
2. Nodality lands $10M to treat malignancies and autoimmune disease (deals.venturebeat.com) [edit]
3. Nodality, Inc.: Series C $3.5M (onbiovc.com) [edit]
4. Nodality gains backing from Pfizer Ventures in $15.5M round Read more: http://www.fiercebiotech.com/story/nodality-gains-backing-pfizer-ventures-15-5m-round/2010-03-22?utm_medium=rss&utm_source=rss#ixzz0ixGe93nH (fiercebiotech.com) [edit]